Merck Wins U.K. Appeal For Propecia Patent
Citing European patent law precedents, a U.K. appellate court has reversed a lower court order revoking Merck & Co. Inc.'s patent for male pattern baldness treatment Propecia, finding that Actavis UK...To view the full article, register now.
Already a subscriber? Click here to view full article